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ABSTRACT 
 
Induction of premature senescence in human fibroblasts through endoplasmic reticulum stress: 
protection by phenolic diterpenes 
 
Population ageing is increasing worldwide due to the increase of lifespan and to sociological reasons. 
This is however associated with a higher incidence of age-related chronic disorders, such as 
neurodegenerative and cardiovascular diseases, diabetes and cancer. Therefore, new approaches to 
promote a healthy ageing are needed. The accumulation of damaged and misfolded proteins are 
present during the ageing process and known to be associated with endoplasmic reticulum (ER) stress 
and to the progression of many age-related diseases. Based on this, an in vitro method to induce 
premature senescence in normal human fibroblasts through induction of ER stress was developed in 
the present study in order to test potential anti-ageing compounds that acts by dealing with protein 
damage and associated ER stress. 
Tunicamycin (TUN) was successfully used to induce ER stress in normal diploid human skin fibroblasts 
since it triggered the unfolded protein response (UPR) signaling, as shown by the up-regulation of BiP, 
ATF6-, CHOP and spliced XBP1. Treatment of fibroblasts with TUN significantly inhibited cell growth 
without inducing cell death (even by apoptosis), and it affected cell morphology in a way that resembled 
a senescent phenotype. Induction of premature senescence was confirmed by the appearance of 
several markers of cellular senescence, such as induction of G1 arrest, presence of SA 
-Gal positive cells, increased cells’ green autofluorescence and expression of p16. Finally, this model 
was used to test the potential protective effect of carnosic acid - a natural phenolic diterpene. Although 
preliminary, the results suggested us that carnosic acid is able to prevent against the TUN-induced 
premature senescence corroborating the anti-ageing potential of this compound shown by previous 
results from the group. 
This work contributed to the development of a new model of induction of premature senescence in 
human fibroblasts, which can then be used to test compounds applicable for nutritional ageing 
interventions. 
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RESUMO 
 
Indução de senescência prematura em fibroblastos humanos através de stress no retículo 
endoplasmático: proteção por diterpenos fenólicos 
 
O envelhecimento da população está a acontecer de uma forma crescente devido ao aumento da esperança 
média de vida e por razões sociais. Contudo, este fenómeno está associado ao aumento da incidência de 
doenças crónicas relacionadas com o envelhecimento, tais como doenças neurodegenerativas e 
cardiovasculares, diabetes e cancro. Portanto, novas abordagens são necessárias de modo a promover um 
envelhecimento saudável. A acumulação de proteínas danificadas está presente durante o processo de 
envelhecimento e é reconhecido a sua associação ao stress do retículo endoplasmático (ER) e com a 
progressão de muitas doenças relacionadas com o envelhecimento. Deste modo, no presente estudo foi 
desenvolvido um método in vitro de indução de senescência prematura em fibroblastos humanos normais 
através da indução de stress do ER, de modo a testar compostos com potencial anti-envelhecimento que 
atuam por modulação dos níveis de proteínas danificadas e o associado stress do ER. 
 
A tunicamicina (TUN) foi usada com sucesso em fibroblastos diplóides normais isolados de pele humana 
para indução de stress do ER, uma vez que ativou a unfolded protein response (UPR) demonstrado pelo 
aumento observado da expressão de BiP, ATF6-, CHOP e spliced XBP1. O tratamento dos fibroblastos 
com TUN inibiu significativamente o crescimento celular sem, porém, induzir morte celular (incluindo 
apoptose), mas afetou significativamente a morfologia das células de tal modo que mimetizava um fenótipo 
de senescência. A indução de senescência prematura foi confirmada através da presença de diversos 
marcadores de senescência celular, tais como a indução da paragem do ciclo celular em G1, presença de 
células marcadas com -Gal, aumento da autofluorescência verde e da expressão de p16. Finalmente, este 
modelo foi usado para testar os potencias efeitos protetores do ácido carnósico - um diterpeno fenólico. 
Embora preliminares, os resultados sugerem que este composto previne contra a senescência prematura 
induzida pela TUN, corroborando assim o seu potencial efeito anti-envelhecimento anteriormente 
demonstrado pelo grupo. 
Este trabalho contribuiu para o desenvolvimento de um novo modelo de indução de senescência prematura 
em fibroblastos humanos, o qual pode ser usado para testar compostos aplicáveis em intervenções 
nutricionais para o envelhecimento. 
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“Nothing in life is to be feared, it is only to be understood.  
Now is the time to understand more, so that we may fear less.” 
 
Marie Curie 
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1. INTRODUCTION 
 
Tissue degeneration and loss of physiological function is a common problem that accompanies Human 
ageing (Levine et al., 2009). That loss of function is caused by a progressive damage of tissues. It is 
documented that during skin ageing the replicative cycle leads to exhaustion of the capacity of cells for 
division and for their specialized functions (Campisi, 1998). The apoptotic death pathways also play an 
important role to maintain the tissue homeostasis and its failure leads to accumulation of errors that 
contribute to several problems like skin ageing (Haake et al., 1998, Levine et al., 2009). Therefore, 
regulation of cell death program is of the utmost importance. To mimic the ageing process in vitro cells 
isolated from various tissues can be used, such as human skin diploid fibroblasts. This type of cells 
show a limited proliferation potential in vitro (Hayflick limit) before they enter a state of permanent 
growth arrest named as senescence (Hayflick, 1992). In this state cells remain metabolically active but 
completely indifferent to mitogenic stimuli (Hayflick et al., 1961). It is documented in literature that 
after entering the senescence state, human fibroblast arrest in G1 phase of cell cycle (Stein et al., 
1995). 
A group of heterodimeric enzymes named cyclin-dependent kinases (CDK’s) (Nigg, 1995) are 
responsible to control the evolution of cell cycle and their activity is controlled through cellular inhibitor 
protein, the cyclin-dependent kinase inhibitors (CDKI’s), that block the catalytic activity of the CDK’s 
(Peter, 1997). The expression of CDKI’s plays an important role in senescence and they are used as 
bio-markers.  
During the last 50 years, the experimental work related with ageing research led to the formulation of 
several mechanistic theories of biological aging. Two theories of these have been the most studied in 
biogerontology research, the Free-Radical and the Protein Error (Rattan, 2006). The first, Free Radical 
Theory of Ageing (FRTA), was proposed in 1956 and take in consideration that the ageing phenomenon 
are related to a variety of ROS that can lead to molecular damage and functional disorders, diseases 
and death (Rattan, 2006). The second theory is known as Protein Error Theory of Ageing (PETA). Since 
errors in protein synthesis are much more frequent than errors in the synthesis of nucleic acids, this 
theory became more relevant to ageing (Rattan, 2006, 2008a). Several evidences that support PETA 
come from experiments that show that the induction and increased errors in proteins can accelerate the 
ageing of human cells and bacteria (Holliday, 1996; Rattan, 1996, 2003; Nyström, 2002). 
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The endoplasmic reticulum (ER) is a multifunctional organelle responsible for lipid biosynthesis, calcium 
storage and release and most important, membrane protein folding. An alteration of ER homeostasis 
leads to the formation of misfolded or unfolded proteins, ER stress and consequently activation of some 
defense mechanisms like the unfolded protein response (UPR) (Naidoo, 2009). The ER stress can have 
a significant role in the ageing process. Its malfunction can lead to several diseases, such as diabetes, 
inflammation and neurodegenerative disorders (Park et al., 2013) as will be discussed later. 
Diet and the consumption of different bioactive natural compounds can have a huge importance in the 
modulation of the ageing process. It is known that a diet rich in fruits vegetables and aromatic herbs 
are associated with a lower incidence of ageing-related disorders, such as neurodegenerative and 
cardiovascular diseases and some types of cancer (Willett, 1995; Temple, 2000; Liu, 2003; 
Neuhouser, 2004; Ferrari, 2004, Everitt et al., 2006). Many reports already attributed beneficial effects 
of several non-nutrient natural compounds to the human health, such as flavonoids and other 
polyphenols, sulfuraphanes, among others (Stanner et al., 2004; Willcox et al., 2004; Obrenovich et al., 
2011, Gerhäuser, 2012). In particular, phenolic diterpenes like carnosic acid (CA) are known for their 
direct antioxidant effects as well as by the ability to induce intracellular antioxidant defenses (Martin et 
al., 2003; Satoh et al., 2008, Kelsey et al., 2010). These properties are very important to the 
prevention of age-related diseases and to modulate the ageing process itself.  
1.1. The Ageing Process 
Ageing is an arising phenomenon characteristic of protected environments due to the survival of the 
individuals beyond the natural lifespan in the wild (Rattan et al., 2005). It is a concept that cannot be 
defined just considering the genetic of the individuals. In fact, there is no genetic program that 
determine the survival duration of an organism as no genes have been found whose function is to 
cause ageing (Rose, 1991; Kirkwood et al., 2000, Gavrilov et al., 2001, Rattan, 2005). Instead, ageing 
varies among different species, among organisms inside the same species, in each tissue and organ 
from the same organism, among different type of cells and their compartments as well as 
macromolecules (Holliday, 2000, Rattan, 2000). Ageing can be considered a condition that requires 
alterations not only in the organism but also in their organs, tissues, cells and macromolecules 
(Holliday, 1995; Rattan, 1996, Rattan et al., 2005). This phenomenon is characterized by a gradual 
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accumulation of molecular damage in nucleic acids, proteins and lipids that lead to a loss of biological 
functions of cells. The progression and consequences of ageing are dependent of the combination of 
the individuals’ genetic background and environment (Rattan et al., 2005). 
The homeostasis of an organism is totally dependent of the success of the cellular maintenance, repair 
and turnover machinery. Their inefficiency and failure leads to an accumulation of molecular damage 
and errors that are in the origin of ageing and age-related diseases (Holliday, 2000). In a society where 
the medical care increasingly extends the lifespan of human beings resulting in an increased aged-
population, the development and success of research in the prevention of the onset of age-related 
diseases is of great importance in order to improve life quality at older age (Rattan et al., 2005). 
Diseases such Alzheimer and Parkinson (Wick et al., 2000, Tezil et al., 2013), cancer and 
cardiovascular problems (Wick et al., 2000; Khurana et al. and Tezil et al., 2013) as well as 
osteoporosis (Wick et al., 2000) are characteristic of the old ages. Almost all of these diseases have in 
common the cell deterioration caused by accumulation of damaged macromolecules and right before 
culminating in cell death, some of these cells experiment a state of senescence where they gradually 
loss the capacity to proliferate (Jeyapalan et al., 2008). 
1.1.1. Cellular Senescence: a marker of the ageing process 
The loss of ability of cells to divide is a characteristic of cellular senescence. This process is 
characterized by a limited potential of cells for proliferation in culture called the Hayflick limit. Hayflick 
and Moorhead showed in 1961 that human fibroblasts initially undergo robust cell division in culture 
but gradually the proliferation decline with time culminating in the cessation of cell division – replicative 
senescence (Hayflick et al., 1961). The cells that loss their capacity to divide, remain metabolic active 
(Campisi, 2013) and viable for many weeks but cannot grow even in the presence of nutrients 
(Campisi, 2007). It was also shown that senescence could serve as a tool for fighting cancer since it 
could be used to halt the uncontrolled proliferation of cancer cells. The cell senescence was also 
considered a barrier to cellular repair since it takes the cells to a state of growth arrest (Hayflick, 1992). 
Mitotic cells are those that have the ability to proliferate but also have the ability to maintain a state of 
quiescence (G0 state). The cells in G0 state are able to go back to a state of proliferation in response to 
appropriate signals, including the need for tissue repair or regeneration (Campisi, 2007). These cells, 
like fibroblasts are susceptible to undergo cellular senescence when challenged by certain stimulus, 
which induces the loss of their capacity for cell division and perform their normal biological functions. 
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The senescent phenotype (Figure 1) is induced by different stimuli (such dysfunctional telomeres; 
chromatin perturbations; DNA damage and strong mitogen signals caused by activated oncogenes) and 
stresses (as oxidative stress). This phenotype is characterized by growth arrest, apoptosis resistance 
and altered gene expression (in pathways related with immune response and inflammation, 
cytoskeleton, stress response, and metabolism) (Campisi et al., 2007). On the other hand, the post-
mitotic cells are incapable of proliferation. They are considered differentiated cells, such neurons, and 
not senescence cells. 
 
 
Figure 1: The senescent phenotype induced by multiple stimuli. (from Campisi et al., 2007) 
 
Special proteins are actively expressed in senescent cells that lead to irreversible growth arrest, such as 
the CDKI’s, p21 (or CDKN1a, p21Cip1, Waf1 or SDI1) and p16 (or CDKN2a or p16INK4a) (Hara et al., 
1996, Campisi, 2007). These CDKI’s are controlled by the p53 and Rb (retinoblastoma), two tumour-
suppressor proteins involved in the cells’ growth arrest. p21 is activated directly by p53 but the 
mechanism of activation of p16 is not very well understood (Gil et al., 2006). 
The senescent cells are known to be correlated with the secretion of proteins that can alter the 
microenvironment of cells that surround those (Alcorta et al., 1996, Trougakos et al., 2006). An 
example of this happens with senescent fibroblasts that have an altered gene expression and 
overexpress specific proteins, which induce inflammation and remodel the extracellular matrix (Campisi, 
2007). 
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Cellular senescence is directly associated with ageing, since pathologies related with age accumulate 
senescent cells and their numbers increase with age (Campisi, 2007). There are diverse age-related 
diseases that present senescence-associated markers. Previous studies reported the presence of 
senescent endothelial cells in atherosclerotic plaques as other arterial lesions (Fenton et al., 2001; 
Minamino et al., 2002; Matthews et al., 2006). Senescent cells were also detected in chrondrocyte 
clusters with mitotic activity nearly to osteoarthritic lesions (Price et al., 2002) and in benign prostatic 
hyperplasia (disorder that affect aging male population) where the presence of senescent epithelial cells 
promote the continuum growth of the transition zone of the prostate (Choi et al., 2000; Castro et al., 
2003). Other cases were the presence of senescent cells alter the microenvironment of tissues is aged 
skin. Here, the secretion of inflammatory cytokines, degradative enzymes and growth factors by dermal 
fibroblasts has been correlated with aged skin morphology (Jenkins, 2002; Hornebeck, 2003; 
Boukamp, 2005). It is also discussed that the presence of senescent cells contributes to the stimulation 
of growth and angiogenic activity in premalignant cells (Martens et al., 2003; Bavik et al., 2006; Coppe 
et al., 2006) promoting the progression of these cells leading to carcinogenesis. 
1.1.2. Premature Senescence: models in normal human fibroblasts 
In order to better understand the senescence phenomenon in vitro, and to do not depend solely in the 
replicative senescence (which takes several months to be completed), methods of induction of 
premature senescence were developed. Several studies have shown that early passage normal human 
diploid fibroblasts can develop a phenotype similar to replicative senescence (such as the inability to 
replicate in response to diverse growth factors, reduced activity of certain cell cycle-related enzymes 
and enlarged cell size) in response to several stress factor such oxidants (Chen et al., 1994; von 
Zglinicki et al., 1995; de Magalhães et al., 2004, Burova et al., 2013), inhibitors of histone deacetylase 
(Ogryzko et al., 1996), hyperactivation of RAS gene (Serrano et al., 1997 and Lee et al., 1999) and 
overexpression of E2F1 transcription factor (Dimri et al., 2000). Stress-induced premature senescence 
(SIPS) is the designation of young cells that experience a state of premature senescence caused by 
diverse stimuli. Several stressors are in the origin of premature senescence and many models are used 
to induce that. It has been reported that mesenchymal stem cells in vitro, when subject to oxidative 
stress (Brandl et al., 2011; Kim et al., 2012, Ko et al., 2012) or ionization radiation (Wang et al., 2009; 
Prendergast et al., 2011, Cmielova et al., 2012) undergo stress-induced premature senescence. In the 
model of induction of premature senescence with oxidants, it was observed that after a 2 hours pulse 
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treatment with sub-cytotoxic concentrations of H2O2, cells lose the capacity to replicate and develop a 
senescent phenotype (Chen et al., 1994, Chen, Q. et al., 2000). This model of treatment causes a 
transient increase of p53 protein and inhibition of Rb hyperphosphorilation (Chen et al., 1998).  
SIPS exhibit common features with replicative senescence such as senescent morphology, senescence-
associated -galactosidase (SA -gal) activity, growth arrest in G1 phase of the cell cycle, elevation of 
p21 and underphosphorylation of Rb (Chen et al., 1998). SIPS differs from replicative senescence in 
that p53 is only transiently elevated (Chen et al., 1998). These similarities turn the SIPS a viable model 
to study senescence in vitro. 
1.2. Endoplasmic Reticulum: Response to Stress 
The endoplasmic reticulum (ER) is a multifunctional organelle constituted by a network of membranes 
that extends throughout the nucleus to the cytoplasm (Naidoo, 2009). This complex organelle is 
responsible for multiple tasks like calcium storage, lipid biosynthesis and is the place where the 
synthesis, folding and maturation of secretory and membrane proteins occurs (Samali et al., 2009). A 
balance between the protein load and the folding capacity is tightly regulated to maintain the 
homeostasis of cells (Oslowski et al., 2011). Any change in this balance caused by physiological or 
pathological stimuli can easily lead to ER stress. The ER stress results from accumulation of misfolded 
and unfolded proteins that activate a complex signaling network known as unfolded protein response 
(UPR) (Oslowski et al., 2011). But if for some reason the mechanism of UPR fails, ER stress can lead to 
cell death and disease (Kim et al., 2008). ER stress is involved in various diseases with high incidence, 
such as diabetes, cancer and neurodegeneration (Ron et al., 2007), which makes the ER stress 
pathways an important target for the study of new drugs against these diseases and ageing. 
1.2.1. Role of Chaperones in Protein Folding 
ER chaperones are a group of proteins important in the process of folding of proteins and in the 
maintenance of ER homeostasis. This process involves different chaperones such as the glucose 
regulated protein 78 (GRP78, also known as Immunoglobulin Binding Protein - BiP) and 94 (GRP94), 
lectins, calnexin, calreticulin, thiol-disulfide oxidoreductases, protein disulfide isomerase (PDI) and 
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ERp57. All these are responsible for the correct folding of proteins and many decreases with age 
(Naidoo, 2009).  
BiP chaperone has a crucial role in the maintenance of cell homeostasis. In ER, it binds transiently to 
newly synthesized proteins and more permanently to misfolded, underglycosylated or unfolded proteins 
in order to correct them (Gething et al., 1992, Gething, 1997) by interacting with the hydrophobic 
domains (Naidoo, 2009). BiP also functions to maintain the permeability barrier of the ER membrane 
by sealing the luminal end of the translocon pore before and early in translocation (Hamman et al., 
1998). When proteins are unable to fold properly they are retained in the ER and this accumulation of 
misfolded proteins results in the transcriptional up-regulation of many genes, including the one that 
encodes for BiP (McMillan et al., 1994, McNees et al., 1997, Lee, 2005). Such malfolded protein 
accumulation has been associated to neurodegenerative disorders such as Alzheimer’s and Parkinson’s 
diseases, as well as prion protein diseases (Lee, 2005), and therefore, the correct function and 
activation of BiP is of high importance.  
1.2.2. Unfolded Protein Response 
When the homeostasis of ER is disrupted by physiological and pathological stimuli, misfolded and 
unfolded proteins accumulate in the lumen of ER, a condition known as ER stress (Liu et al., 2003; Lai 
et al., 2006, Bravo et al., 2013). ER stress activates a set of signalling pathways via different transducer 
proteins, a process called UPR, that aims to reduce ER stress and restore homeostasis (Liu et al., 
2003; Ron et al., 2007; Malhotra et al., 2007; Walter et al., 2011, Bravo et al., 2013). When the 
homeostasis of ER is disrupted, several ER sensors with transmembranar domains are triggered and a 
compensatory response is activated (Bravo et al., 2013). Any increase of accumulation of misfolded or 
unfolded proteins in ER lumen, is noticed by the luminal sensor domains and then transduced to 
cytoplasm and nucleus by different pathways that act in parallel and/or in series (Schönthal, 2012; 
Park et al., 2013). The process by which the UPR are trigered with accumulation of misfolded and 
unfolded proteins is not yet well understood. However, it is known that the BiP chaperone is involved 
(Gething, 1999, Naidoo, 2009). In unstressed cells, besides their chaperone function, much of the BiP 
is bonded to the UPR protein mediators keeping them inactive. With accumulation of misfolded and 
unfolded proteins, BiPs are released from UPR protein transducers to bind the hydrophobic region of 
unfolded proteins via a substrate binding domain to facilitate their proper folding or to otherwise send 
them to degradation by the ER-associated protein degradation (ERAD) machinery in the cytosol (Figure 
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2) (Ahner et al., 2004, Jarosch et al., 2003). The ERAD process can be divided on four steps: 
recognition, retrotranslocation, ubiquitination and degradation in the proteossome (Yoshida et al., 
2001).  
Although questioned by more recent works, many authors consider BiP as a master regulator of the 
UPR (Kohno et al., 1993), since upon ER stress, BiP dissociates from the UPR transmembranar protein 
sensors, resulting in their activation (Figure 2) (Oslowski et al., 2011). The first one is PKR-like ER 
Kinase (PERK), a transmembranar kinase that after ER stress oligomerizes, autophosphorylates and 
directly phosphorylates eIF2 (Oslowski et al., 2011). The phosphorylated eIF2α avoids the 
construction of ribossomal initiation complexes thereby reducing the mRNA translation (Harding et al., 
2000a). However, some mRNA is still translated in particular the ones involved in the UPR for ER stress 
restoration (Oslowski et al., 2011). Phosphorilated PERK also have the function to activate the b-ZIP 
transcription factor ATF4 that regulates de several UPR genes such CHOP (Harding et al., 2000b), and 
to phosphorylate the Nrf2 transcription factor that is involved in the up-regulation of several antioxidant 
and protective genes (Naidoo, 2009). The second UPR regulator is the Inositol Requiring Enzyme 1 
(IRE1 protein,) a transmembrane serine/ threonine kinase that senses ER stress by its N-terminal 
luminal domain (Urano et al., 2000a). IRE1 dimerizes and autophosphorylates to be active. Two 
isoforms of this protein are known: IRE1 that is expressed in all types of cells and is the most studied 
and the IRE1 (Oslowski et al., 2011). IRE1 splices the X-box binding protein 1 (XPB-1) mRNA that 
encodes a basic leucine zipper (b-ZIP) transcription factor that upregulates UPR target genes such as 
chaperones for correct protein folding (Calfon et al., 2002; Shen et al., 2001, Yoshida et al., 2001). The 
last UPR regulator is the Activating Transcription Factor 6 (ATF6) a transmembranar  transcription 
factor that when activated under ER stress conditions transits to the Golgi where it is cleaved by S1P 
and S2P generating an activated b-ZIP transcription factor (Ye et al., 2000). This form travels to the 
nucleus activating UPR genes responsible for protein folding, processing and degradation (Haze et al., 
1999, Yoshida et al., 2000). 
 
 
11 
 
Figure 2: Scheme showing the activation of UPR and signaling of adaptative and protective responses to ER 
stress by the three UPR-protein transducers. Misfolded proteins are recognized by the BiP chaperone that if not 
properly folded are targeted for degradation by the ERAD machinery. Upon ER stress the transmembranar 
proteins PERK, IRE1 and ATF6 are activated regulating many transcriptions factors that upregulate genes with 
functions of adaptive response, feedback control, and cell fate regulation. (from Naidoo et al., 2008) 
 
Therefore, activated UPR aims an adaptive response to the ER stress by increasing the cellular protein-
folding capacity and to reduce protein influx into the ER by inhibiting protein translation (Oslowski et al., 
2011, Bravo et al., 2013). It also encompasses an increase in ERAD machinery and autophagy 
components to promote clearance of unwanted proteins, as well as a feedback control involving the 
negative regulation of UPR activation to prevent harmful hyperactivation when ER homeostasis is 
reestablished (Oslowski et al., 2011, Bravo et al., 2013). If these protective and adaptative measures to 
limit protein load and alleviate ER stress fails, UPR signal cell fate by activating pathways that leads 
usually to cell death by apoptosis, which plays an important role in the pathogenesis of ER stress-
related disorders (Oslowski et al., 2010). 
12 
1.2.3. ER Stress and Disease  
When the ER stress persists for a long time and the UPR fails to restore protein homeostasis in the ER, 
to ultimately protect the organism against mal-functioning cells, a pathway of cell death by apoptosis is 
usually activated. UPR-associated cell death are known to contribute to the pathogenesis of a number 
human diseases, including diabetes mellitus, neurodegenerative disorders, chronic inflammation, and 
certain forms of conformational diseases that are characterized by a decreased ability of cells to 
respond to stress (Bartoszewska et al., 2013). During ageing, it is also known that responsiveness of 
the UPR system to ER stress declines (Salminen et al., 2010). Therefore, accumulation of misfolded 
proteins happens that quickly leads to the formation of protein aggregates. These small aggregates are 
very toxic for the cell and may impair the ubiquitin proteasome pathway that leads to even more 
accumulation of aggregates (Yoshida et al., 2007). Thus, the failure of the cell machinery responsible 
for the degradation of proteins – the ERAD pathway, leads to several types of problems culminating in 
cell death and diseases (Park et al., 2013). 
Both type 1 and type 2 diabetes involve beta-cell dysfunction and/or apoptosis, which are associated 
with ER stress (Back et al., 2012, Wang et al., 2012). In an initial phase, type 2 diabetes (non insulin-
dependent) is associated to a hyper-secretion of insulin that leads to insulin resistance in peripheral 
tissues (Shore et al., 2011, Hetz et al., 2013). This production of large amounts of insulin by beta-cells 
culminates in the induction of ER stress followed by beta-cell death. Therefore, in later phases of 
diabetes development, loss of beta-cells and lack of insulin production happens due to ER stress (Shore 
et al., 2011). Neurodegenerative diseases like Alzheimer’s or Parkinson’s are correlated with unfolded 
proteins and protein aggregates that trigger the ER stress and cell death (Yoshida et al., 2007, Sano et 
al., 2013). In fact, neurons are thought to be sensitive to protein aggregates, and there are many 
reports showing that ER stress is involved in neurodegeneration (Forman et al., 2003; Lindholm et al., 
2006, Yoshida et al., 2007). Alzheimer’s disease is the most common neurodegenerative disease, and 
is characterized by cerebral neuritic plaques of amyloid beta-peptide. Many reports suggest a strong 
causal relationship between ER stress and Alzheimer’s disease, where is thought that accumulation of 
amyloid beta-peptide can trigger ER stress and that contributes to neurodegeneration (Yoshida et al., 
2007). Parkinson’s disease is the second most common neurodegenerative disease and is 
characterized by a loss of dopaminergic neurons. Although it is still unclear whether the ER stress 
response is involved with Parkinson’s disease, many findings strongly suggest a link between them. For 
example, Parkinson’s disease is characterized by the presence of Lewy bodies, aggregates of alpha-
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synuclein protein; and, one of the genes involved in the disease encodes the protein Parkin that is a 
ubiquitin-protein ligase (E3) involved in the ERAD machinery (Yoshida et al., 2007). Among of other 
diseases, what is also related with ER stress is atherosclerosis (the accumulation of homocystein 
induces ER stress increasing the expression of BiP and CHOP); certain types of inflammation (for 
example in nervous system where interferon gamma induces ER stress); ischemia; heart, liver and 
kidney diseases (Yoshida et al., 2007). 
Considering the involvement of ER stress in several diseases and ageing, understanding its 
mechanisms of action and their modulation by natural food constituents can be helpful for the 
prevention and treatment of these diseases (Yoshida et al., 2007; Park et al., 2013). 
1.2.4. Inducers of ER Stress 
Several chemicals are capable of inducing ER stress in vitro like tunicamycin (TUN), thapsigargin, 
dithiothreitol (DTT), Brefeldin A and MG132 (Oslowski et al., 2011). The inducers of ER stress are 
usually grouped in different classes depending of their mechanisms of action. In one of these classes 
are compounds that work as disruptors of Ca2+ homeostasis. The best known are the ionophore A23187 
and the Ca2+ pump inhibitor thapsigargin. Since the Ca2+ concentration in ER is at high levels and ER 
chaperones like BiP need Ca2+ ions for their function, the use of these Ca2+ disruptors leads to ER stress 
(Doner et al., 1990; Price et al., 1992, Oslowski et al., 2011). 
Another class of ER stressors is composed by reducing agents. For the proper folding of proteins the 
formation of disulfide bonds is necessary between cysteine residues. This requires the presence of a 
very strong oxidative environment in the ER (Tu et al., 2004, Xu et al., 2005). The use of reducing 
agents will prevent the formation of these disulfide bonds and, consequently, ER stress occurs due to 
accumulation of misfolded proteins. The two most common reducing agents used are 2--
mercaptoethanol and dithiothreitol (DTT) (Brostrom et al., 1995; Fernandez et al., 1996, Oslowski et 
al., 2011). 
In the case of brefeldin A, it induces ER stress by impeding the transport of proteins from ER to the 
Golgi and from Golgi apparatus to ER, leading therefore to accumulation of unfolded proteins (Oslowski 
et al., 2011). On the other hand, MG132 is a chemical that inhibits the proteasome that belongs to the 
ERAD machinery, leading to an accumulation of misfolded and unfolded proteins in the ER (Oslowski et 
al., 2011). 
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The last class of chemicals, and the most used, is of compounds that inhibit glycosylation of proteins. 
Most proteins are N-glycosylated, a post-translational modification very important for protein folding. A 
chemical that can inhibit protein glycosylation is TUN, an antibiotic produced by Streptomyces 
lysosuperificus. It acts by a mechanism that prevent UDP-N-acetylglucosamine-dolichol phosphate N-
acetylglucosaminephospho transferase (GPT), in other words, TUN blocks the formation of correctly 
folded proteins by inhibition of glycoprotein biosynthesis in the ER (Oslowski et al.,2011). 
1.3. Biological Effects of Carnosic Acid 
Rosemary (Rosmanirus officinalis L.) is an aromatic plant with several medical properties. Both the herb 
and its oil are used in food processing for spicing and flavouring (Ho et al., 1994). It is traditionally used 
as herb and has analgesic and anti-microbial properties (Newall, 1996, López-Jiménez et al., 2013). 
Rosemary is known for it antioxidant effect. In fact, the European Union legislation allows the use of 
rosemary extracts by the food companies labelling it as “antioxidant: rosemary extract” (López-Jiménez 
et al., 2013). The directives 2010/67/EU and 2010/69/EU refer the use of rosemary extracts as safe, 
effective and a natural alternative to synthetic antioxidants (López-Jiménez et al., 2013). Carnosic acid 
(CA) is a natural occurring phenolic compound found in rosemary. It is a phenolic diterpene with special 
characteristics. CA is a compound with antioxidant properties that is being assigned to the prevention or 
even to the treatment of some diseases related with oxidative stress and inflammation (López-Jiménez 
et al., 2013). In addition, CA possesses antimicrobial, antiobesity, antiplatelet and antitumor activities 
(Takahashi et al., 2009; Kelsey et al., 2010; Bernardes et al., 2010; Yesil-Celiktas et al., 2010, López-
Jiménez et al., 2013). 
Besides being a direct antioxidant compound, CA induces also the expression of several intracellular 
antioxidant defences, such as phase II and antioxidant enzymes NAD(P)H:quinone oxidoreductase 1 
(NQO1), glutathione S-transferase (GST), -glutamyl cysteine ligase (-GCL), ferritin and heme 
oxygenase-1 (HO-1) (Macé K et al., 1998; Dinkova-Kostova, 2002; Iqbal et al.,2003, Itoh et al., 2004). 
This antioxidant response is known to be mediated throught Nrf2 signalling. Nrf2 is a transcriptional 
factor that is also activated by the PERK pathway during ER stress (Cullinan et al.2003), and when it 
accumulates in the nucleus activates the transcription of genes that encode for phase II and antioxidant 
enzymes (Cullinan et al., 2003, Itoh et al., 2004). 
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Because CA possesses both antioxidant and promotes of defence pathways in cells, it can be viewed as 
a compound with potential to protect against ER stress, which will be tested in this project. 
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OBJECTIVES OF THE WORK 
 
The research of our laboratory group has been focused in the study of the pharmacological properties 
of natural compounds. The age-related diseases have been the main target of the research goals and 
previous studies have been performed in order to test the anti-ageing effects of some polyphenols, such 
as quercetin, luteolin, rosmaniric acid, curcumin and phenolic diterpenes. 
Related with the ageing process and its possible modulation by natural compounds, it is currently 
ongoing in the laboratory the funded FCT project NaturAge (PTDC/QUI-BIQ/101392/2008). In this 
project, the potential anti-ageing properties of natural compounds are being tested in human skin 
fibroblasts in models of SIPS and replicative senescence. In particular, phenolic diterpenes, such as CA, 
were shown to induce antioxidant defences in human skin fibroblasts through Nrf2 signaling and to 
prevent significantly H2O2-induced premature senescence (Carvalho et al., 2013, unpublished data). 
In the current master work, done under the NaturAge project, the objective of the study was to evaluate 
the ability of ER stress to induce premature senescence in normal human skin fibroblasts, and then to 
use this as model to study the anti-ageing properties of CA. Since the UPR that follows ER stress is 
known to activate Nrf2 signaling, because CA also activates Nrf2 in human fibroblasts we hypothesize 
that it would protect against ER stress-induced premature senescence. To follow the previous aims and 
hypothesis the following questions were addressed: 
1) Is the inducer of ER stress TUN able to trigger cellular senescence in normal diploid skin human 
fibroblasts? 
2) Is the phenolic diterpene CA able to protect against ER stress-induced premature senescence in 
fibroblasts? 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIAL AND METHODS 
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2. MATERIALS AND METHODS 
2.1. Cell Culture and Treatment 
Normal diploid adult human skin fibroblasts (ASF-2 cells) were kindly provided by Prof. Suresh Rattan 
(University of Aarhus, Denmark), which were isolated from a breast biopsy specimen from a consenting 
young healthy Danish woman (aged 28 years) (Lima C.F et al., 2011). Cells were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 
10% fetal bovine serum (FBS) (Biochrom KG; Berlin, Germany) and 1% antibiotic/antimycotic solution 
(100U/ml penicillin and 100 mg/ml streptomycin; Sigma-Aldrich) and grown under an atmosphere of 
5% CO2 in air at 37 °C. For subculturing, confluent cells were washed in phosphate buffered saline 
(PBS; 137 mM NaCl, 2.7 mM KCl, 8.5 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4) and treated with 0.25% 
Tripsyn-EDTA solution (Sigma-Aldrich) for cell detachment. 
For experiments, cells were seeded at a density of 5×104 cell/ml onto 12-well culture plates for MTT,  
β-Gal and One Step Growth Curve assays (0.8 ml/well), 6-well culture plates for Western Blotting and 
Nuclear Condensation assays (2 ml/well), 60 mm petri dish for cytometry (5 ml/dish) and 100 mm 
petri dish for real-time PCR (10 ml/dish). To induce ER stress, cells were treated with TUN (AppliChem; 
Darmstadt, Germany) from stock solutions prepared in dimethyl sulfoxide (DMSO) and maintained at -
20 °C in aliquots. Twenty-four hours after plating, the medium was discarded and replaced with fresh 
medium containing TUN with the desired concentration ensuring that the DMSO concentration did not 
exceed 0.5% (v/v). Controls received DMSO only. The time and concentration of TUN used for the 
different experiments is described below and/or in the Results section. Carnosic acid (CA; ChromaDex, 
Irvine, CA, USA) was used to test its ability to prevent TUN toxicity, and for that a stock solution was 
made in DMSO and used in cell culture as described for TUN. 
2.2. Cell Viability: MTT Assay 
The evaluation of cell viability was performed by a colorimetric assay using the dye 
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) as before (Lima C.F et al., 
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2011). MTT assay relies on the capacity of cells to reduce the water soluble yellow-coloured MTT in a 
water-insoluble blue-coloured formazan that can be then measured spectrophotometrically after 
dissolution with appropriate solvent. Only live cells with active mitrochondria will reduce MTT, enabling 
this assay for cell viability and proliferation studies (Hatok J. et al., 2009). 
To evaluate the effect of different concentrations of TUN on cell viability, two incubation regimes were 
used: continuous incubation with TUN for 48 hours, and 4 hours-pulse incubation with TUN plus 
44 hours with fresh medium without TUN. Two hours before the end of the incubation, 40 µl of 5 
mg/ml MTT solution (Sigma-Aldrich) was added to each well. Then, medium was carefully removed and 
formazan crystals were dissolved with 800 µl of DMSO/etanol (1:1 v/v) solution. The absorbance of 
solution was read at 570 nm using a microplate reader spectrophotometer (SpectraMax Plus384, 
Molecular Devices; Sunnyvale, CA, USA) using 690 nm as reference. A well with solvent was used as 
blank. Cell viability was presented as percentage of the negative control (cells without TUN). 
2.3. One Step Growth Curve 
The effects of TUN 5 µM on cell proliferation was also estimated using a One Step Growth Curve, where 
the number of cells was estimated by cell counting in a Neubauer chamber. After incubating cells with 
TUN for 48 hours, medium was replaced by fresh medium without TUN and incubated for more 3 days 
(first 5 days-growth curve). Then, a second 5 days-growth curve in the absence of TUN was performed 
after subculturing cells and refreshing the medium 48 hours after cell seeding. 
2.4. Cell Cycle Analysis by Flow Cytometry 
For cell cycle analysis, TUN (1 and 5 µM) was incubated with ASF-2 cells using two incubation regimes: 
continuous incubation with TUN for 24 hours, and 4 hours-pulse incubation with TUN plus 20 hours 
with fresh medium without TUN. After incubation, cells were washed with PBS and collected for tubes 
after treatment with 0.25% Trypsin-EDTA solution. Cells were centrifuged and rinsed with PBS before 
fixation with ice-cold 70% (v/v) ethanol solution for 30 minutes. Then, cells were washed with PBS, 
resuspended in 500 µl of PBS, and incubated for 15 minutes at 37°C after addition of 50 µl of a 
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200 µg/ml RNase A solution. Later, 60 µl of 0.5 mg/ml propidium iodide (Sigma-Aldrich) stain solution 
was added and incubated at room temperature for 15 minutes before sample analysis. Cell cycle were 
analysed by flow cytometry using a Coulter Epics XL flow cytometer (Beckman Coulter; Inc., Miami, FL, 
USA) collecting data from at least 20,000 single cells per sample. The fit of cells to each cell phase was 
performed using the Flow Jo software (Tree Star, Ashland, OR, USA) as before (Xavier CP et al., 2012). 
2.5. Senescence-Associated -Galactosidase (SA--Gal) Staining 
Senescent cells were evaluated by the SA -Gal staining assay as before (Dimri et al., 1995).In this 
method, fixed cells are incubated with the chromogenic substrate 5-bromo-4-chloro-3-indolyl -D-
galactopyranoside (X-Gal), and when cleaved by -galactosidase originates an insoluble blue compound 
observable by microscopy. -Gal positive cells obtained at pH 6 are considered senescent (Bassaneze, 
V. et al. 2008, Debacq-Chainiaux et al., 2009).  
For this assay, cells were incubated with 5 µM TUN for 4, 24 and 48 hours followed by a recovery 
period in fresh medium without TUN up to 5 days. After that, cells were subcultured and seeded in new 
wells at a density of 5×104 cells/ml. One day after plating, cells were washed twice with PBS and fixed 
with 4% (w/v) paraformaldehyde for 5 minutes at room temperature. After washing cells with PBS, they 
were incubated with a fresh staining solution (1 mg/mL X-Gal, 5 mM potassium ferricyanide, 5 mM 
potassium ferrocyanide, 150 mM NaCl, 2 mM, MgCl2, 40 mM citric acid/phosphate buffer at pH 6.0) at 
37 °C in a humidified chamber overnight. After that, -Gal-positive (blue) cells were observed and 
counted using a phase-contrast microscope (Olympus IX71, Hamburg, Germany). 
2.6. Cell Size and Lipofuscin-Related Green Autofluorescence 
Analysis by Flow Cytometry 
Induction of senescence in human fibroblasts is associated with the increase of cell size and lipofuscin 
content (Bayreuther et al., 1988). Lipofuscin are fine dense granular pigments that accumulate during 
ageing and result from non degradable material on lysosomes (Brunk et al., 2002). Lipofuscin presents 
increase green autofluorescence and therefore it can be estimated in a flow cytometer (Brunk et al., 
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2002, Sitte et al., 2001). In this work, flow cytometry was used to detect both changes in cell size and 
lipofuscin-related green autofluorescence as done in a previous work (Martin-Ruiz et al., 2004). 
For this assay, cells were incubated with TUN (1 µM and 5 µM) using two incubation regimes: 
continuous incubation with TUN for 24 hours, and 4 hours-pulse incubation with TUN plus 20 hours 
with fresh medium without TUN. Then, cells were washed with PBS and collected for tubes after 
treatment with 0.25% Trypsin-EDTA solution. Cells were centrifuged for 5 minutes at 700 xg and at 4°C 
and resuspended in 500 µl of PBS. Cells were then analyzed on a flow cytometer (Beckman Coulter; 
Epics XL) counting at least 15,000 events in each sample measuring both cell size (FSC) and green 
autofluorescence. The data was treated using the FlowJo software. 
2.7. Nuclear Condensation Assay 
To estimate cell death by apoptosis, the presence of nuclear condensation in cells was performed as 
described previously (Dias et al., 2013). Cells were incubated with TUN (1 µM and 5 µM) using two 
incubation regimes: continuous incubation with TUN for 48 hours, and 4 hours-pulse incubation with 
TUN plus 44 hours with fresh medium without TUN. After the incubation time, both floating and 
adherent (after treatment with 0.25% Trypsin-EDTA solution) cells were collected for tubes, washed with 
PBS, and fixed with 4% (w/v) paraformaldehyde in PBS for 15 minutes at room temperature. Cells were 
then washed with PBS and attached into a polylysine-treated slide using a Shandon Cytospin 4 (Thermo 
Scientific, Waltham, MA, USA) and nuclei stained with Hoechst. Apoptosis was identified by the 
presence of cells with condensated and fragment nuclei under a fluorescence microscope (Olympus 
IX71). The percentage of apoptotic cells were calculated from the ratio between cells presenting nuclear 
condensation and the total number of cells (nuclei stained with Hoechst) from a count higher than 
500 cells per sample. 
2.8. Western Blotting 
The expression of different proteins after TUN treatment (1 µM and 5 µM) was monitored by western 
blotting. Two incubation regimes were used: continuous incubation with TUN for 24 hours, and 4 hours-
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pulse incubation with TUN plus 20 hours with fresh medium without TUN. Protein extraction was then 
done after washing cells with PBS, where cell pellet was lysed at 4 ºC with a strong lysis buffer (50 mM 
Tris-HCl pH 7.4, 190 mM NaCl, 9 mM EDTA, 0.1% (w/v) sodium deoxycholate. 0.1% (w/v) SDS, 1% 
(w/v) Triton-X 100) supplemented with 20 mM NaF, 20mM Na2V3O4, 1mM phenylmethylsulfonyl 
fluoride, and 1x protease inhibitor cocktail (Roche, Mannheim, Germany). Cell lysate was centrifuged at 
10,000 xg at 4 ºC for 10 minutes and protein concentration quantified by the Bio-Rad DC protein assay 
(Bio-Rad Laboratories, Inc., Hercules, CA, USA) using bovine serum albumin (BSA) as protein standard. 
For western blot analysis, 20 µg/ml of protein of each sample was separated by 10% sodium dodecyl 
sulphate (SDS)-polyacrylamide gel during approximately 1 hour at 150 V and electroblotted to a 
Hybond-P polyvinylidene difluoride membrane (GE Healthcare, Bucks, UK) during 40 minutes at 15 V 
using a semi-dry electroblotting system (Trans-blot SD semi-dry transfer cell, Bio-Rad Laboratories). The 
membranes were then blocked in TPBS (PBS with 0.05% (v/v) Tween-20) containing 5% (w/v) non-fat 
dry milk during 2 hours, washed in TPBS and incubated with primary antibody at the appropriate 
dilution overnight at 4 °C. The primary antibodies used were: anti-ATF6- (H-280), anti-p27, anti-
phospho-JNK and anti-JNK from Santa Cruz Biotechnology, Inc (Dallas, Texas, USA) and anti-GRP78 
(BiP) from Abcam Inc. (Cambridge, MA, USA). Afterwards the membranes were washed with TPBS and 
incubated with appropriate horseradish peroxidase-conjugated secondary antibodies for 1 hour at room 
temperature. The secondary antibodies HRP donkey anti-rabbit and sheep anti-mouse were from Santa 
Cruz Biotechnology, Inc. The immunoreactive bands were detected using the Immobilon solutions 
(Millipore, Billerica, MA, USA) and acquired by a chemiluminescence detection system (Chemi Doc 
XRS; Bio-Rad Laboratories, Inc.). To ascertain comparative expression and equal loading of the protein 
samples, expression of -actin was performed using an antibody from Sigma-Aldrich. 
2.9. Study of Gene Expression by Real-Time PCR 
The effect of TUN on the expression of chosen genes related with UPR and senescence was evaluated 
by real-time PCR. Human fibroblasts were incubated with TUN (1 µM and 5 µM) during 6 hours and, 
after washing with PBS, cells were collected for tubes after treatment with 0.25% Trypsin-EDTA solution, 
centrifuged, homogeneized in the appropriate volume of RNA Lysis Buffer (from the kit bellow) and cell 
lysate kept at -80 ºC until use. 
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2.9.1. Total RNA isolation 
Total RNA of human fibroblasts was extracted using the SV Total RNA Isolation System kit (Promega, 
Madison, WI, USA) following manufacturer’s instructions. In brief, lysate was thawed on ice, mixed with 
RNA Dilution Buffer and centrifuged. Then, the supernatant was transferred to a fresh tube and placed 
in a heating block at 70°C for 3 min. After adding 95% ethanol, the mixture was transferred to a spin 
column in a collection tube, centrifuged, washed with RNA Wash Solution (RWA) and then the DNase 
treatment was made. Finally, the tube was washed with RWA and the isolated RNA eluted into an 
elution tube. 
Total RNA concentration and purity were determined in the NanoDrop 1000 spectrophotometer 
(Thermo Scientific). The ratio of absorbance at 260 nm and 280 nm (A260/A280) was used to assess 
the purity of RNA. An absorption ratio of approximately 2.0 was accepted as “pure” for RNA. 
2.9.2. cDNA synthesis 
cDNA synthesis was performed using the  iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Inc., 
Hercules, CA, USA) following manufacturer’s instructions. 1 µg of extracted total RNA was reverse 
transcribed using a thermal cycler (MyCycler, Bio-Rad Laboratories, Inc) using the following protocol 
5 minutes at 25 °C; 60 minutes at 42 °C and 5 minutes at 85 °C. The obtained cDNA was stored at  
-20 °C. 
2.9.3. Real-time PCR 
After cDNA synthesis, three genes were chosen (Table 1) to study their expression by real-time PCR. 
The primers used were designed as a previous work (Oslowski et al. 2011, Tani et al., 2010) and are 
detailed in Table 1. It was previously confirmed its specificity to the chosen human genes using an 
online tool (Primer Blast) thereby authenticating their alignment. The primers were synthesized by STAB 
Vida, Lda (FCT UNL, Caparica, Portugal). The lyophilized primers were dissolved in nuclease-free water 
to obtain a concentration of 100 µM. The primers specificity and efficiencies were verified in a CFX96™ 
Real-Time PCR Detection System (Bio-Rad Laboratories, Inc.) by performing a melting curve. Real-time 
PCR efficiencies were calculated according to Pfaff (2001) from the data provided by software CFX 
Manager (Bio-Rad Laboratories, Inc). For the real-time PCR reaction a mastermix was prepared with the 
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following components: 10 µl of mix from SsoFast EvaGreen Supermix kit (Bio-Rad Laboratories, Inc.) 
following the manufacturer’s instruction, 1 µl of forward primer and 1 µl of reverse primer, 7 µl of 
water. Then the mastermix (19 µl) was filled in a proper multiplate for PCR reactions and 1 µl of cDNA 
(50 ng) was added as PCR template. For amplification and detection a CFX96™ Real-Time PCR 
Detection System (Bio-Rad Laboratories, Inc.) was used. The following real-time PCR protocol was used 
for all genes: denaturation program (3 minutes at 95 °C), amplification and quantification program 
repeated 40 times (10 seconds at 95 °C; 30 seconds at 60 °C with a single fluorescent measurement) 
followed by melting curve program (65 °C to 95 °C with a heating rate of 0.5 °C/s and continuous 
fluorescent measurements). GAPDH (primers available in the laboratory and design by us) was used as 
internal control. Results were obtained by the comparative Ct method (Pfaffl, 2001), and expressed as 
fold change with respect to the control. 
 
 
Table 1: List of primers used to detect ER stress and senescence markers by real-time PCR (1Oslowski et al., 
2011 and 2Tani et al., 2010). 
Gene 
(Human) 
Primer Forward Primer Reverse 
Product 
Length (bp) 
CHOP1 AGAACCAGGAAACGGAAACAGA TCTCCTTCATGCGCTGCTTT 67 
sXBP11 CTGAGTCCGAATCAGGTGCAG  
ATCCATGGGGAGATGTTCTGG 
 
59 
usXBP11 
CAGCACTCAGACTACGTGCA 
 
76 
p162 GTGGACCTGGCTGAGGAG CTTTCAATCGGGGATGTCTG 132 
GAPDH AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 123 
28 
2.10. Statistical Analysis 
As appropriate, Students’ t-test or one-way ANOVA followed by the Student-Dunnetts’ post-hoc test was 
used to perform statistical analysis for MTT, -Gal assay, cell cycle, cell size and real-time PCR data. 
GraphPad Prism 5.0 software (San Diego, CA, USA) was used and P-values ≤ 0.05 were considered 
statistically significant. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
  
  
31 
3. RESULTS 
3.1. Tunicamycin Inhibits the Growth of Human Fibroblasts 
The first objective of this work was to test whether the induction of ER stress by TUN was able to induce 
premature senescence in normal human skin fibroblasts (ASF-2 cells). For that, first the effect of 
different concentrations of TUN on cell viability was studied and measured by the MTT reduction assay. 
Two incubation procedures were used: continuous incubation with TUN for 48 hours, and a 4 hours-
pulse incubation with TUN followed by 44 hours with fresh medium without TUN (recovery period). This 
continuous and pulse incubation with TUN was generally followed along all the work. 
As shown in Figure 3A (white bars), TUN decreased cell growth by about 30% in a concentration-
dependent manner from 0.02 to 0.5 µM in the continuous incubation. From 1 to 20 µM the cell growth 
continued to be further inhibited but much more slightly and no significant cell death was observed, as 
shown by the absence of floating cells under microscopic observations (Figure 3B). With the 4 hours-
pulse incubation (Figure 3A – grey bars) cell growth was only significantly decreased at the 
concentration of 5 µM of TUN, where about 30% inhibition was also reached. Similarly to the 
continuous incubation, no significant cell death was observed with the highest TUN concentration tested 
(Figure 3B). 
To verify whether TUN induced cell death by apoptosis in ASF-2 cells the nuclear condensation assay 
was performed. We observed that TUN did not induced apoptosis after 48 hours of treatment until the 
concentration of 20 µM (data not shown). These results confirmed that TUN is not cytotoxic to human 
fibroblasts in the conditions used.  
Besides the absence of floating cells and the visible decrease of cell number along with increasing 
concentrations of TUN, it is also interesting to observe in Figure 3B that cell morphology changed 
considerably with induction of ER stress. Control cells present normal morphology like being small, thin 
and elongated with parallel arrangement in culture; on the contrary, TUN-treated cells (specially with 
higher concentrations) present increased cell size with flattened and irregular morphology, loss of 
parallel arrangement and presence of dense cytoskeletal actin filaments and pigments (Figure 3B). 
These are morphological changes typical of normal fibroblasts undergoing senescence (Rattan, 2008b), 
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Figure 3: Effect of tunicamycin (TUN) in cell viability of human fibroblasts. (A) Effect of different concentrations 
of TUN on cell viability as measured by the MTT assay, after 48 hours incubation both in a continuous and a 4 
hours-pulse TUN treatments. Values are mean ± S.E.M. of at least 3 independent experiments. * P-value < 0.05, 
B 
A 
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(cont. Figure 3) ** P-value < 0.01, when compared with the respective control by the one-way ANOVA followed 
by the Student Dunnett’s post-hoc test, NS, not significant when compared with control (P-value > 0.05) (B) 
Effect of TUN 1 µM (TUN 1) and 5 µM (TUN 5) in cell morphology after 48 hours of incubation with a continuous 
or a 4 hours-pulse treatment. Bar indicates 100 µm. 
 
and therefore this is a good indication that TUN induced inhibition of cell growth associated with a 
senescent-like phenotype.  
Based in these results, it was chosen the concentration of 1 µM and 5 µM for the following studies 
related with induction of UPR and senescence by TUN in normal human fibroblasts. 
3.2. Tunicamycin Induced the Unfolded Protein Response (UPR) 
Tunicamycin is known to induce ER stress followed by the UPR in human cells (Oslowski et al., 2011). 
To confirm that in our cellular model, different UPR parameters were evaluated by western blot and 
real-time PCR. After 24 hours of incubation the protein levels of the ER chaperone BiP and the UPR 
mediator ATF6- changed significantly after TUN treatment both in the continuous and pulse incubation 
(Figure 4A). With accumulation of unfolded and/or misfolded proteins due to ER stress, BiP dissociates 
from the UPR mediators activating them. Activation of UPR signaling pathways results then in the 
transcriptional activation of several genes including BiP in order to increase ER protein folding capacity 
(Naidoo, 2009). As shown in Figure 4A, BiP levels increased remarkably with TUN treatment, and in a 
concentration-dependent manner in the pulse assay, demonstrating the activation of the UPR. 
In the case of ATF6-, after its dissociation from BiP due to ER stress, it transits to the Golgi where the 
full-length protein (90 kDa) is proteolytically cleaved to an active transcription factor of 50 kDa that 
translocates to the nucleus to activate UPR genes (Oslowski et al., 2011). Our results (Figure 4A) show 
that TUN induced a decrease or total disappearance of the inactive form of the protein (90 kDa band), 
most likely due to its cleavage due to the UPR activation. Unfortunately, with the antibody used, we 
were not able to observe the processed active form at 50 kDa (data not shown). An interesting 
observation is that with TUN treatment, mainly at higher concentrations and/or longer exposure time, a 
second band is present with a lower molecular weight (around 80 kDa) than that of the full-length and  
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Figure 4: Effect of tunicamycin (TUN) on UPR signalling. (A) Effect of TUN (1 and 5 µM) in the levels of ATF6-, 
BiP, p-JNK and p27 as measured by western blot, after 24 hours incubation both in a continuous and a 4 hours-
pulse TUN treatments. -Actin was used as loading control. The asterisk denotes the unglycosylated form of the 
full-length ATF6-. Shown blots are representative of 3 independent experiments with similar results. (B) Effect of 
TUN (1 and 5 µM) for 6 hours in the levels of CHOP, unspliced XBP1 (usXBP1) and spliced XBP1 (sXBP1) mRNA 
as measured by real-time PCR. Values are mean ± S.E.M. of at least 3 independent 
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(cont. Figure 4) experiments. * P-value < 0.05, ** P-value < 0.01 and *** P-value < 0.001, when compared 
with control by the one-way ANOVA followed by the Student-Dunnett’s post-hoc test, NS, not significant when 
compared with control (P-value > 0.05). 
 
glycosylated one (Figure 4A). That band corresponds to the unglycosylated form of the full-length  
ATF6- protein (Haze et al., 1999), and, therefore, is in line with the direct effect of TUN, that is the 
inhibition of protein glycosylation. Overall, these western blot results indicate that TUN at 1 and 5 µM 
successfully induced the UPR response in a similar magnitude in the continuous incubation, where as 
in the pulse incubation there was a concentration-dependent effect of TUN, which is in agreement with 
the results of cell growth inhibition above. 
The activation of other UPR signalling pathways, in particular the ones mediated by IRE1 and PERK 
regulators was evaluated by real-time PCR after 6 hours of treatment (Figure 4B). The activation of 
PERK, among other targets, leads to the up-regulation of CHOP that is associated with ER stress-
mediated apoptosis (Oslowski et al., 2011). We observed that the levels of CHOP mRNA increased in a 
concentration-dependent manner, attaining a significant 5x increase at the concentration of 5 µM of 
TUN (Figure 4B).  
The activation of IRE1 signalling was evaluated measuring the levels of spliced XBP1. According to 
Oslowski et al., 2011, IRE1 function as an endoribonuclease that cleaves a 26-nucleotide intron from 
the mRNA of the X-box binding protein (XBP) 1, originating a spliced product (sXBP1) (Figure 5). This 
spliced mRNA encodes for a protein that function as a potent factor of genes that restore the 
homeostasis of ER. As shown in Figure 4B, the expression levels of spliced XBP1 increased remarkably 
with TUN treatment in a concentration-dependent manner, whereas unspliced XBP1 (usXBP1) 
decreased significantly only at the highest concentration of TUN. Therefore, both the mRNA levels of 
CHOP and spliced XBP1 confirms that the UPR is triggered in human fibroblasts treated with TUN. 
Besides splicing of XBP1, the IRE1 mediator is also involved in the activation of JNK pathway through 
ASK1, which is involved in the activation of apoptosis (Nishitoh et al., 2002, 2008 and Oslowski et al., 
2011). Although the expression of the UPR-related gene CHOP associated with apoptosis increased 
after TUN treatment (Figure 4B), JNK signaling decreased as shown by the phosphorylation levels of 
JNK measured by western blot (Figure 4A). This observation is in agreement  
with the absence of apoptosis shown by the lack of nuclear condensation. 
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Figure 5: Representation of spliced product obtained from cleavage of 26-nucleotide intron of XBP1 mRNA and 
the localization of primer forward primers on unspliced and spliced XBP1 mRNA. 
 
3.3. Tunicamycin Induces a Senescence-Like Phenotype in Normal 
Human Skin Fibroblasts 
Considering that TUN inhibited cell growth and triggered the UPR, we then asked whether this ER stress 
would culminate in induction of premature senescence. First, to confirm TUN ability to inhibit cell 
growth, the cell cycle progression was analyzed by flow cytometry. As shown in Figure 6, TUN induced 
a clear increase in the number of cells at G0/G1 phase in both incubation regimes. This was 
accompanied by a significant decrease in the number of cells synthesizing DNA (S phase) and a 
noticeable decrease of cells at G2/M phase. This G1 arrest induced by TUN was concentration-
dependent in both incubation regimes (Figure 6). Regarding the comparison between the two 
incubation regimes used, no appreciable difference was noticed, although the effect was stronger in the 
continuous incubation. Interestingly, a G1 arrest is what is observed in normal fibroblasts undergoing 
replicative senescence (Cristofalo et al., 1989) or premature senescence using other inducer models 
(Zubova et al., 2005. With the cell cycle analysis we also never observed a sub-G1 phase typical of DNA 
fragmentation due to apoptosis (Figure 6B), corroborating once more that TUN did not trigger apoptosis 
in human fibroblasts in the conditions used here. 
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Figure 6: Effect of tunicamycin (TUN) in cell cycle progression. (A) Effect of TUN (1 and 5 µM) in the cell cycle 
phases as measured by flow cytometry, after 24 hours incubation both in a continuous and 4 hours-pulse TUN 
treatments. Values are mean ± S.E.M. of at least 3 independent experiments. * P-value < 0.05 and  
** P-value < 0.01, when compared with the respective phase control by the one-way ANOVA followed by the 
Student-Dunnett’s post-hoc test, NS, not significant when compared with control (P-value > 0.05). (B) 
Representative results of the effect of the 4 hours-pulse of TUN experiment on the distribution of single cells 
through the phases of cell cycle after 24 hours of incubation. 
 
During senescence of human skin fibroblasts cells increase in cell size and accumulate dense bodies 
containing UV-fluorescent pigments such as lipofuscin (Rattan, 2008b, Brunk et al., 2002). Therefore, 
measuring both the increase of cell size and cells’ green autofluorescence by flow cytometry can be 
helpful to study senescence and to distinguish senescent cells (Martin-Ruiz et al., 2004). As can be 
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observed in Figure 7A, in the control condition it was represented a group of 25% of total cells 
presenting higher cell size and/or green autofluorescence, which were considered cells with a 
senescent-like phenotype. 
This box was then maintained fixed during the TUN treatments and, as shown in Figure 7A&B, an 
increase from 25 % (control) to 33 % and 47 % of cells with a senescent phenotype was obtained with 
TUN 1 and 5 µM, respectively. Only measuring mean green autofluorescence a significant increase in 
this parameter was also observed dependent on TUN concentration (Figure. 7B). The mRNA levels of 
p16, a well-known ageing marker associated with inhibition of cell cycle (Campsi, 2007), was also 
measured by real-time PCR. As shown in Figure 7C, TUN induced significantly the expression of p16, 
and therefore this result agrees with the ability of TUN to induce senescence. The protein levels of 
another cell cycle inhibitor, p27, were also increased with TUN treatment (Figure 4A) corroborating thus 
that the cell cycle is stopped after ER stress. 
 
Additionally, a well-known biochemical biomarker for senescence - the SA -Gal staining - was 
performed 5 days after TUN treatment by different periods of time. As shown in Figure 8, TUN 5 µM 
increased in a time-dependent manner the number of cells presenting SA β-Gal staining. Overall, these 
results support that TUN induces premature senescence in normal human skin fibroblasts and seems 
to be irreversible, since after 5 days in culture cells still did not increase in cell number as followed by 
microscopic observations. 
 
To confirm whether the stoppage of cell cycle was or not irreversible, a growth curve in two steps of  
5 days each was performed. In the first one step growth curve of 5 days, cells were incubated with TUN 
5 µM during 48 hours followed by 3 days of recovery in fresh medium (Figure 9B, left panel). 
 
 
 
 
 
 
39 
A 
B 
C 
 
 
 
 
 
 
Figure 7: Effect of tunicamycin (TUN) in cellular senescence parameters. (A) Representative experiment of the 
effect of TUN (1 and 5 µM) in cell size and cells’ green autofluorescence as measured by flow cytometry, after  
24 hours incubation with an initial 4 hours-pulse TUN treatment. The percentage of cells inside the box were 
considered senescent (SEN) based in the last quartile of cells in the control condition with higher cell size and/or 
green autofluorescence. (B) Effect of TUN in the number of cells considered senescent (left panel) and cells’ 
mean green autofluorescence (right panel) as measured by flow cytometry. Cells were treated with  
TUN (1 and 5 µM) during 4 hours followed by a period of recovery of 20 hours in fresh medium. Values are 
mean ± S.E.M. of at least 3 independent experiments. * P-value < 0.05, when compared with control by the one-
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(cont. Figure 7) way ANOVA followed by the Student-Dunnett’s post-hoc test. (C) Effect of TUN (1 and 5 µM) 
for 6 hours in the levels of p16 mRNA as measured by real-time PCR. Values are mean ± S.E.M. of at least 3 
independent experiments. *** P-value < 0.001, when compared with control by the one-way ANOVA followed by 
the Student-Dunnett’s post-hoc test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Effect of tunicamycin (TUN) in the senescence-associated (SA) -Gal staining of human fibroblasts. (A) 
Representative images from the effect of TUN 5 µM (TUN 5) in the SA -Gal positive cells, 5 days after 4 hours-
pulse treatment with TUN. Bar indicates 200 µm. (B) Quantitative analysis of the effects of TUN in the SA -Gal-
positive cells. The fibroblasts were treated with TUN 5 µM during 4, 24 or 48 hours followed by a recovery period 
up to 5 days in fresh medium. Values are mean ± S.E.M. of at least 3 independent experiments. 
** P-value < 0.01, *** P-value < 0.001, when compared with control by the one-way ANOVA followed by the 
Student-Dunnett’s post-hoc test. 
B 
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Figure 9: Reversibility of senescence induced by tunicamycin (TUN) in human fibroblasts. (A) Representative 
images of fibroblasts after 5 days in culture with or without an initial TUN 5 µM (TUN 5) treatment for 48 hours. 
Bar indicates 500 µm. (B) Effect of TUN 5 µM treatment for 48 hours in cell growth during two steps of 5 days 
as measured by cell counting. In the first one step growth curve of 5 days, cells were incubated with TUN 5 µM 
during 2 days followed by 3 days of recovery in fresh medium (left panel). Control and treated cells were then 
counted and subcultured to new wells at the same cell density, and a second one step growth curve of 5 days 
was followed without TUN treatment (right panel). Shown data are representative of two independent experiments 
with similar results. 
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As expected, control cells grew considerably as opposed to TUN-treated cells, where they maintained 
basically the same cell number after cell seeding – a typical response of cells undergoing senescence. 
After this 5 days time period, the difference in cell number between control and TUN-treated cells is well 
visible in Figure 7A. Then, control and TUN-treated cells were subcultured to the same cell density, and 
a second one step growth curve of 5 days was performed without TUN treatment. As shown in Figure 
7B (right panel), control cells grew as usual, and cells that were previously treated with TUN also 
increased in cell number along the time but at lower rate. However, of notice in this experiment is that 
the growth arrest induced by TUN in human fibroblasts typical of senescence was not irreversible. 
Although several markers of cellular senescence were observed after TUN treatment, such as induction 
of G1 arrest, presence of SA -Gal positive cells, increased cells’ green autofluorescence and 
expression of p16, probably a percentage of cells not irreversibly arrested (non senescent) stopped cell 
cycle for recovery from ER stress-induced damage through a successful UPR, and then began to 
proliferate. This hypothesis needs, however, to be confirmed in further experiments. In fact, in a 
preliminary experiment (data not shown), a first treatment of cells with TUN protected them to a second 
TUN insult done after 5 days of a recovery period, probably due to the induction of the UPR due to the 
first treatment dose. 
 
3.4. Carnosic Acid Prevents Against TUN-Induced Premature 
Senescence in Human Fibroblasts  
After characterizing the effects of TUN in normal human fibroblasts in culture where it induced a 
senescence-like phenotype in thecell population, the second objective of the work was to test whether 
the phenolic diterpene CA, known to induce stress-associated cellular antioxidant defences (Carvalho et 
al., 2012 and Satoh et al., 2008), will be able to protect against the premature senescence induced by 
TUN. For that, cells were pre-incubated with the natural compound CA at 10 µM for 16 hours followed 
by incubation with fresh medium containing 5 µM of TUN during 4 hours. Then, cells were left in fresh 
medium for recovery during 5 days (with a mid-time medium refreshment) and cell growth was 
estimated by the MTT assay. 
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The used concentration of CA was previously shown to be toxic non, to not affect cell growth and to able 
to induce cellular antioxidant defences (Carvalho et al., 2012). Here, the ability of CA to induce 
antioxidant defences, such as HO-1 and NQO1 enzymes, was also confirmed by western blot (data not 
shown). 
 
As observed in Figure 10, a 4 hours-pulse incubation with TUN 5 µM inhibited significantly cell growth 
due to cell cycle arrest and induction of a senescent-like phenotype described as above. When the cells 
were pre-treated with CA there was a slight but significant protection against the inhibition of cell growth 
induced by TUN (Figure 10B). By microscopic observations, CA pre-treated condition presented also a 
higher number of cells with the typical parallel arrangement and less number of cells with 
morphological features of senescent cells, such as increased cell size, flattened and irregular 
morphology, and presence of dense cytoskeletal actin filaments and pigments (Figure 10A). Thus, 
CARN was able to prevent in some magnitude normal human fibroblasts from TUN-induced premature 
senescence. This needs, however, to be confirmed in further experiments measuring, for example, SA 
-Gal staining and cells’ green autofluorescence. 
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Figure 10: Ability of carnosic acid (CA) to protect against premature senescence induced by tunicamycin (TUN). 
Normal human fibroblasts were pre-treated with CA during 16 hours in order to activate the cellular protection 
pathways. After that, cells were treated with TUN 5 µM during 4 hours followed by a recovery period in fresh 
medium for 5 days (with a mid-time medium refreshment). In (A) are representative images of cells in the end of 
the experiment. Bar indicates 200 µm. In (B) is the estimation of cell growth by the MTT assay. Values are mean 
± S.E.M. of 3 independent experiments. * P-value < 0.05, when compared with the respective control non-treated 
with TUN; # P-value < 0.05, when compared with each other (compares the effect of pre-treatment with CA). 
Statistical analysis was done using the Students’ t-test. 
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4. DISCUSSION 
 
Human lifespan is increasing over the years due to the improvements in the leaving conditions, diet and 
the health care system (Vaupel, 2010). The higher percentage of elderly people (over 65 years old) is 
associated, however, with a higher incidence of age-related chronic disorders such as diabetes, cancer, 
neurodegenerative and cardiovascular diseases, among others (Rahman, 2007). These diseases affect 
human health at old age inflicting suffering to the people and their families as well as imposing a high 
morbidity and mortality rates. Therefore, finding new strategies to stimulate a healthy ageing would be 
an important approach to prevent age-related diseases. Considering that a balanced diet with a high 
consumption of fruits vegetables and aromatic herbs are generally associated with a decreased risk of 
some age-related diseases (Stanner et al., 2004), interventions through nutritional factors can be a 
good approach to stimulate a healthy ageing. In the present work we aimed to develop an in vitro 
method to induce premature senescence in normal human fibroblasts in order to be used to test 
compounds efficacious against protein damage and associated ER stress, known as an important factor 
in the development of certain age-related diseases as well as the ageing process itself.  
Cellular ageing is characterized by a progressive loss of physiological fitness, leading to increased cell 
damage, and failure of important biological functions (Campsi, 2013). It is well known that human cells 
in culture do not proliferate indefinitely but instead are “mortal”, reaching a limit of divisions called 
Hayflick limit (Hayflick et al., 1961). The cells approach this limit by slowing down their division until 
entering in senescence, a state of total dormancy of the cells (Campisi et al., 2007). After the discovery 
of the senescent phenotype in cultured cells, the replicative senescence of human cells were applied in 
the research associated to several pathological diseases, such as in cancer therapies (Kuilman et al., 
2010), treatment of atherosclerotic plaques (Fenton et al., 2001; Minamino et al., 2002; Matthews et 
al., 2006) and lesions (Price et al., 2002), and ageing interventions resulting in lifespan extension 
(Haines et al., 2013).   
During the ageing process, an important role is attributed to damage to proteins, which is associated 
with the accumulation of inactive or partial active enzymes (Rothstein, 1979, 1989; Rattan, 1996; 
Gershon, 1979 and Rosenberg, 1991). In senescent cells, it is also reported the accumulation of 
abnormal enzymes and proteins due to protein misfolding and/or unfolding (Gafni, 1990; Rattan, 
2008a). To overcome the time needed to follow the replicative senescence, several protocols of 
induction of premature cellular senescence in early passage cells have been developed. Premature 
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senescence can be triggered by exposure of normal diploid human fibroblasts to subcytotoxic 
concentrations of different stressors, such as hydrogen peroxide, ethanol, UV light and -irradiation 
(Ryazanov et al., 2002). These stressors induce senescence by induction of reactive oxygen species 
(ROS) and/or direct damage against DNA. However, it is also known that accumulation of damaged 
proteins also happens, and when that accumulation turns prolonged, stress to the ER is triggered (Lai 
et al., 2007 and Oslowski et al., 2011). Since induction and increased damaged to proteins can 
accelerate the ageing of human cells (Rattan, 1996, 2003), in this project we attempted to develop a 
method of premature senescence in normal human fibroblasts using an inducer of ER stress. In our 
experimental model, TUN was used, which is a drug that inhibits the glycolisation of proteins, leading to 
their misfolding and accumulation in the ER causing ER stress and activation of the UPR pathway 
(Zamarbide et al., 2013). 
Incubation of normal diploid human skin fibroblasts with TUN resulted in cell growth inhibition in a 
concentration-dependent manner, but not in cell death. As expected by previous results (Samali et al., 
2010; Bull et al., 2012), TUN induced the UPR signaling as a mechanism of defense against the ER 
stress, in view of the increase of BiP protein levels and cleavage of ATF6-, as well as increased 
expression of CHOP and spliced XBP1 mRNAs. Contrary to previous results using different cell types 
(Ming-Zhi et al., 2010 and Jung et al., 2012), TUN did not induce apoptosis in human fibroblasts, as 
shown by the absence of nuclear condensation, lack of a fraction of cells at the sub-G1 phase by flow 
cytometry, and decreased levels of phospho-JNK. However, CHOP expression increased, and this 
protein in generally associated with ER stress-mediated apoptosis. 
Interestingly, after TUN treatment cells presented s morphology typical of senescent cells, such as 
increased cell size with flattened and irregular morphology, loss of parallel arrangement and presence 
of dense cytoskeletal actin filaments and pigments. In addition, cell cycle stopped at G0/G1 phase, 
which is also what is observed after replicative senescence (Pignolo et al., 1997, Mao et al., 2012). To 
understand whether TUN was inducing premature senescence to the human fibroblasts or simply the 
cell cycle was being arrested to solve the ER stress through the UPR activation, markers of cellular 
senescence were evaluated. TUN treatment induced an increase in cell size and green cells’ 
autofluorescence (a measure of ageing-associated lipofuscin content), as well as an increase in the 
expression of p16 and in the number of SA -Gal positive cells. An increase in all of these parameters is 
characteristic of senescent cells, and is considered hallmarks of ageing (Brunk et al., 2002, Rattan, 
2008b). To clarify whether this senescent-like phenotype would be clearly associated with induction of 
49 
premature senescence, we then tested whether the growth arrest was irreversible. One week after TUN 
treatment, cells began to growth almost as good as the control cells. That indicates that at least a 
fraction of cells were not irreversibly growth arrested and, therefore, were not senescent. Other 
approaches that induces premature senescence, such as treatment of human fibroblasts with hydrogen 
peroxide (H2O2) that makes use of induction of oxidative stress to onset cellular senescence (Kiyoshima 
et al., 2012 and Wang et al., 2013), two pulse treatments with the stressor is needed to suitably induce 
premature senescence (Chen et al., 2004). This was also attempted here with a time period of one 
week between the two treatments, but a protective response was obtained instead of a more 
pronounced senescent phenotype (preliminary experiment). This happened with TUN probably due to 
the protective response elicited by it – the UPR. In future experiments it can be attempted a short time 
between the pulse incubations with TUN to try to avoid the protective UPR response. 
Nevertheless, because in the short time (one week), TUN treatment resembled well a senescent 
phenotype, the protective role of a known antioxidant phenolic diterpene was studied. We have chosen 
the natural compound CA, which is well known for its antioxidant effects (Chipault et al., 1952) and its 
ability to induce intracellular antioxidant defenses (al-Sereiti et al., 1999). Previous results in our 
laboratory showed the ability of CA to increase cellular antioxidant defenses through Nrf2 activation in 
human fibroblasts, which afforded further protection against an oxidative insult and against H2O2-
induced premature senescence (Carvalho et al., 2013, unpublished results). Also Satoh et al., 2008 
documented the ability of CA to induce an antioxidant protection in cerebrocortical neurons against 
oxidative stress, excitotoxicity, and ischemic injury via Nrf2-mediated induction of phase 2 antioxidant 
enzymes. That showed the capacity of this diterpene to function as a prospective therapeutic 
compound. A previous report by Itoh et al., 2004 also showed that when cells were treated with CA, 
cellular antioxidant defenses increased via transcriptional activation of the Nrf2, such as the phase 2 
and antioxidant enzymes, HO-1, NQO1, -GCL, ferritin, and GST. Since the activation of Nrf2 
transcriptional pathway is triggered by the UPR-mediated PERK phosphorylation,which is crucial for cell 
homeostasis during ER stress (Cullinan et al., 2003), we hypothesize that the pre-treatment of human 
fibroblasts with a compound able to induce antioxidant defenses through Nrf2 would protect against the 
TUN-induced premature senescence. In fact, in previous studies, cells knockout for Nrf2 revealed an 
increase of apoptosis and a decrease of cell survival in response to TUN treatment (Cullinan et al., 
2003), showing how important is Nrf2 signalling for cell survival after TUN treatment. Interestingly, in 
our work we observed a slight but significant protection of CA against the inhibition of cell growth 
induced by TUN. In addition, less number of cells with a morphology resembling senescent cells was 
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visible in the CA-treatment condition. It seems, therefore, that CA was also able to prevent against the 
TUN-induced premature senescence, although more studies is needed to confirm this and the 
involvement of Nrf2 induction by the phenolic diterpene in its protective response.  
All these results indicate that ER stress can trigger a senescent phenotype in human fibroblasts and 
corroborate the importance of damage to proteins in the ageing process. This model of premature 
senescence developed here with TUN can be useful to find new compounds that may modulate the 
ageing process and ER stress in diseases associated with it, such as diabetes and neurodegenerative 
disorders. Finally, CA presented an interesting protective potential against the TUN-induced premature 
senescence in normal human fibroblasts and may be viewed in the near future as a nutritional 
approach for ageing interventions. 
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5. FINAL REMARKS AND FUTURE PRESPECTIVES 
5.1. Final Remarks and Conclusions 
Accumulation of damaged proteins is known to be an important factor contributing to the ageing 
process. Unfolded and misfolded proteins induce ER stress and, if unsolved by the UPR, it can 
contribute to the progression of age-associated diseases, such as neurodegenerative disorders and 
diabetes. In this work, a protocol for induction of premature senescence triggered by ER stress was 
developed in normal diploid human skin fibroblasts using TUN as a stressor agent. TUN induced growth 
inhibition of human fibroblasts caused by cell cycle arrest at G1/G0 phase without inducing significant 
cell death. The UPR was triggered after TUN treatment confirming, therefore, the induction of ER stress 
due to inhibition of protein glycosylation. 
After TUN treatment fibroblasts presented a morphology typical of a senescent state, in particular cells 
were bigger, flattened and with irregular edges, they loss their typical parallel arrangement and 
presented dense filaments and pigments. In addition, cells were growth arrested for about one week. 
Induction of premature senescence by TUN was confirmed by the presence of a high percentage of 
cells positive for SA -Gal staining and containing the lipofuscin-associated green autofluorescence, as 
well as a high expression of p16 mRNA. However, one week after TUN treatment cells began to 
proliferate, probably because not all cells (non-senescent ones) were irreversibly growth arrested and 
were only dealing with the ER stress through a successful UPR.  
Using this TUN-induced premature senescence model in normal human fibroblasts, the protective 
potential of the phenolic diterpene CA was assessed. Although preliminary, our results showed the 
capacity of CA to significantly prevent senescence-associated features induced by TUN in human 
fibroblasts. 
With this work we contributed to the development of a new approach to study compounds with potential 
anti-ageing properties through ameliorating the ER stress due to accumulation of misfolded and 
damaged proteins. The potential of CA to possess positive effects during the ageing process and to 
prevent age-related diseases, such as Alzheimer and diabetes, was also corroborated with this work. In 
addition, these results agree with the assumption that consumption of fruits, vegetable and food spices 
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promotes a healthy ageing due to the presence of bioactive phytochemicals, which can be viewed as 
interesting nutritional modulators in ageing interventions. 
5.2. Future Prespectives 
Despite the global advance performed in this work, further experiments need to be done to answer and 
clarify remaining questions. 
As previous mentioned, the induction of premature senescence by the ER stress inducer TUN was not 
attained for all cells, and after one week cells began to proliferate. A hypothesis raised was that a 
fraction of cells were not irreversibly growth arrested and, after recover from the ER stress, these cells 
began to proliferate overriding senescent ones. This needs to be clarified in following experiments, for 
example by sorting cells in a cell sorter after TUN treatment based in the intensity of green 
autofluorescence and cell size, as done in a previous work (Martin-Ruiz et al., 2004). The method of 
induction of premature senescence through of ER stress can also be significantly improved. A possible 
strategy to increase the percentage of senescent cells can be by imposing to cells two pulse incubations 
with TUN separated by a determined time period. Another strategy would be to use two different ER 
stress inducers that act by different mechanisms, incubating cells with one followed by the other. 
As mentioned before, the protective potential of CA against TUN-induced premature senescence needs 
to be confirmed by measuring more senescent-associated parameters, such as SA -Gal positive cells 
and p16 expression. The role of Nrf2 signalling in the protection afforded by CA can be studied by 
siRNA against this transcription factor. Would also be interesting to study other natural compounds in 
this model of premature senescence by using compounds known to have anti-ageing effects, such as 
carnosine (Boldyrev et al., 2013). 
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